Cargando…

129 Urine Osmolality (Uosm) Is a Reasonable Marker of Acute (TKV) and Longer-term (eGFR) Efficacy of Vasopressin Receptor Antagonism in ADPKD: Post-hoc Analysis of TEMPO 3:4

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973164/ http://dx.doi.org/10.1053/j.ajkd.2021.02.134

Ejemplares similares

Neural basis for regulation of vasopressin secretion by anticipated disturbances in osmolality
por: Kim, Angela, et al.
Publicado: (2021)

Effect of a Somatostatin Analogue on the Vasopressin Pathway in Patients With ADPKD
por: Messchendorp, A. Lianne, et al.
Publicado: (2019)

Urine Concentrating Capacity, Vasopressin and Copeptin in ADPKD and IgA Nephropathy Patients with Renal Impairment
por: Zittema, Debbie, et al.
Publicado: (2017)

Wnt ligands regulate Tkv expression to constrain Dpp activity in the Drosophila ovarian stem cell niche
por: Luo, Lichao, et al.
Publicado: (2015)

Measuring and Estimating GFR and Treatment Effect in ADPKD Patients: Results and Implications of a Longitudinal Cohort Study
por: Ruggenenti, Piero, et al.
Publicado: (2012)

WNK1 promotes water homeostasis by acting as a central osmolality sensor for arginine vasopressin release
por: Jin, Xin, et al.
Publicado: (2023)

Per-Treatment Post Hoc Analysis of Clinical Trial Outcomes With Tolvaptan in ADPKD
por: Mallett, Andrew J., et al.
Publicado: (2021)

High water intake and low urine osmolality are associated with favorable metabolic profile at a population level: low vasopressin secretion as a possible explanation
por: Brunkwall, Louise, et al.
Publicado: (2020)

Key influence of sex on urine volume and osmolality
por: Perinpam, Majuran, et al.
Publicado: (2016)

Hyponatremia presenting with hourly fluctuating urine osmolality
por: Son, Raku, et al.
Publicado: (2020)

Predicting changes in osmolality
por: Yang, Zhe, et al.
Publicado: (2021)

NephroCheck: should we consider urine osmolality?
por: Noto, Alberto, et al.
Publicado: (2019)

Heterogeneous Cardiovascular Profiles in CKD: ADPKD Versus non-ADPKD
por: Au, Eric H.K., et al.
Publicado: (2022)

Temporal and geographical external validation study and extension of the Mayo Clinic prediction model to predict eGFR in the younger population of Swiss ADPKD patients
por: Girardat-Rotar, Laura, et al.
Publicado: (2017)

Effect of vasopressin V2-receptor antagonist tolvaptan on syndrome of inappropriate antidiuresis (SIAD) after transsphenoidal pituitary surgery: recovery of measured osmolality
por: Tosaka, Masahiko, et al.
Publicado: (2022)

Hypo-osmolality in beer drinkers
por: Hilden, Tage, et al.
Publicado: (1975)

Antenatally Diagnosed ADPKD
por: Aldridge, Melanie, et al.
Publicado: (2018)

Intrafamilial Variability of ADPKD
por: Lanktree, Matthew B., et al.
Publicado: (2019)

Validation of a urine color scale for assessment of urine osmolality in healthy children
por: Kavouras, Stavros A., et al.
Publicado: (2015)

Effect of tolvaptan in Japanese patients with autosomal dominant polycystic kidney disease: a post hoc analysis of TEMPO 3:4 and TEMPO Extension Japan
por: Muto, Satoru, et al.
Publicado: (2021)

Effect of fortification on the osmolality of human milk
por: Elia, Serena, et al.
Publicado: (2023)

Glomerular filtration rate and urine osmolality in unilateral ureteropelvic junction obstruction
por: Gheissari, Alaleh, et al.
Publicado: (2013)

The association of urine osmolality with decreased kidney function and/or albuminuria in the United States
por: Kitiwan, Boonsong K., et al.
Publicado: (2021)

Calculated plasma osmolality at hospital admission correlates well with eGFR and D-Dimer, a simple outcome predictor and guiding tool for management of severe COVID-19 patients
por: Ramesh, Jayanthy, et al.
Publicado: (2021)

Vasopressin antagonism in heart failure: a review of the hemodynamic studies and major clinical trials
por: Urbach, Jonathan, et al.
Publicado: (2021)

Simultaneous laparoscopic nephrectomy in ADPKD
por: Baishya, Ramen Kumar, et al.
Publicado: (2010)

Polycystins, ADPKD, and Cardiovascular Disease
por: Kuo, Ivana Y., et al.
Publicado: (2019)

Defining Cardiac Dysfunction in ADPKD
por: Kuo, Ivana Y.
Publicado: (2023)

Cardiovascular Manifestations and Management in ADPKD
por: Sagar, Priyanka S., et al.
Publicado: (2023)

Evaluation of conductivity‐based osmolality measurement in urine using the Sysmex UF5000
por: Yoo, Dong‐Won, et al.
Publicado: (2020)

Is urinary density an adequate predictor of urinary osmolality?
por: Souza, Ana Carolina P, et al.
Publicado: (2015)

Individualized Fortification Influences the Osmolality of Human Milk
por: Kreins, Nathalie, et al.
Publicado: (2018)

Use of Urine Electrolytes and Urine Osmolality in the Clinical Diagnosis of Fluid, Electrolytes, and Acid-Base Disorders
por: Kamel, Kamel S., et al.
Publicado: (2021)

The importance of quantifying genetic heterogeneity in ADPKD
por: Chapman, Arlene B.
Publicado: (2014)

Renal Transcatheter Arterial Embolization for ADPKD
por: Oda, Yasuhiro, et al.
Publicado: (2020)

Renal Volume in ADPKD Patient Evaluation
por: Galliani, M., et al.
Publicado: (2020)

The imaging of total kidney volume in ADPKD
por: Cavoli, Gioacchino Li, et al.
Publicado: (2020)

The Impact of COVID-19 on Patients With ADPKD
por: Kutky, Meherzad, et al.
Publicado: (2021)

Germline Mutations for Kidney Volume in ADPKD
por: Kataoka, Hiroshi, et al.
Publicado: (2021)

Imaging Biomarkers in Young Patients With ADPKD
por: Yang, Xinyi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2ig7ce1k61gthipr40h2vtroc8